Document Detail


The use of glucan as immunostimulant in the treatment of a severe case of chromoblastomycosis.
MedLine Citation:
PMID:  18444974     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We report the case of an alternative treatment for a patient with a severe form of chromoblastomycosis that responded poorly to the traditional antifungal therapy. We hereby show, in this study, the improvement of lesions after treatment with itraconazole associated with an intramuscular administration of glucan. We observed that the regression of lesions was associated with an improvement of the cellular immune response. This favourable response that we observed suggests that the therapeutic regimen we used might be an option for the treatment of patients with a severe form of chromoblastomycosis.
Authors:
Conceição de Maria Pedrozo e Silva Azevedo; Sirley Garcia Marques; Maria Aparecida Resende; Azizedite Guedes Gonçalves; Daniel Vagner de Castro Lima Santos; Raimunda Ribeiro da Silva; Maria da Glória Teixeira de Sousa; Sandro Rogerio de Almeida
Related Documents :
1446494 - Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary...
8360134 - Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fu...
18076664 - Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis ...
9071624 - Treatment of onychomycosis: a randomized, double-blind comparison study with topical bi...
2897784 - Nizatidine and ranitidine in the short-term treatment of duodenal ulcer: a cooperative ...
8572784 - Anterior ischemic optic neuropathy after open heart operations.
Publication Detail:
Type:  Case Reports; Letter     Date:  2008-04-28
Journal Detail:
Title:  Mycoses     Volume:  51     ISSN:  1439-0507     ISO Abbreviation:  Mycoses     Publication Date:  2008 Jul 
Date Detail:
Created Date:  2008-10-14     Completed Date:  2008-11-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8805008     Medline TA:  Mycoses     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  341-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adjuvants, Immunologic / therapeutic use*
Antifungal Agents / therapeutic use*
Chromoblastomycosis / drug therapy*
Drug Therapy, Combination
Glucans / immunology*
Humans
Itraconazole / therapeutic use*
Male
Middle Aged
Chemical
Reg. No./Substance:
0/Adjuvants, Immunologic; 0/Antifungal Agents; 0/Glucans; 84625-61-6/Itraconazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Aspergilloma in a pulmonary hydatid cyst: a case report.
Next Document:  Degradation of 16S rRNA and attributes of viability of viable but nonculturable probiotic bacteria.